Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11357186rdf:typepubmed:Citationlld:pubmed
pubmed-article:11357186lifeskim:mentionsumls-concept:C0205127lld:lifeskim
pubmed-article:11357186lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:11357186lifeskim:mentionsumls-concept:C0475224lld:lifeskim
pubmed-article:11357186lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:11357186lifeskim:mentionsumls-concept:C1552430lld:lifeskim
pubmed-article:11357186lifeskim:mentionsumls-concept:C1555766lld:lifeskim
pubmed-article:11357186pubmed:issue3lld:pubmed
pubmed-article:11357186pubmed:dateCreated2001-5-17lld:pubmed
pubmed-article:11357186pubmed:abstractTextIschaemic preconditioning in rats was studied using MRI. Ischaemic preconditioning was induced, using an intraluminal filament method, by 30 min middle cerebral artery occlusion (MCAO), and imaged 24 h later. The secondary insult of 100 min MCAO was induced 3 days following preconditioning and imaged 24 and 72 h later. Twenty-four hours following ischaemic preconditioning most rats showed small sub-cortical hyperintense regions not seen in sham-preconditioned rats. Twenty-four hours and 72 h following the secondary insult preconditioned animals showed significantly smaller lesions (24 h = 112 +/- 31 mm(3), mean +/- standard error; 72 h = 80 +/- 35 mm(3)), which were confined to the striatum, than controls (24 h = 234 +/- 32 mm(3), p = 0.026; 72 h = 275 +/- 37 mm(3), p = 0.003). In addition during lesion maturation from 24 to 72 h post-secondary MCAO, preconditioned rats displayed an average reduction in lesion size as measured by MRI whereas sham-preconditioned rats displayed increases in lesion size; this is the first report of such differential lesion volume evolution in cerebral ischaemic preconditioning.lld:pubmed
pubmed-article:11357186pubmed:languageenglld:pubmed
pubmed-article:11357186pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11357186pubmed:citationSubsetIMlld:pubmed
pubmed-article:11357186pubmed:statusMEDLINElld:pubmed
pubmed-article:11357186pubmed:monthMaylld:pubmed
pubmed-article:11357186pubmed:issn0952-3480lld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:ReidD GDGlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:CampbellC ACAlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:DoddrellD MDMlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:HockingsP DPDlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:ChalkJ BJBlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:MullinsP GPGlld:pubmed
pubmed-article:11357186pubmed:authorpubmed-author:HadinghamS...lld:pubmed
pubmed-article:11357186pubmed:copyrightInfoCopyright -Copyright 2001 John Wiley & Sons, Ltd.lld:pubmed
pubmed-article:11357186pubmed:issnTypePrintlld:pubmed
pubmed-article:11357186pubmed:volume14lld:pubmed
pubmed-article:11357186pubmed:ownerNLMlld:pubmed
pubmed-article:11357186pubmed:authorsCompleteYlld:pubmed
pubmed-article:11357186pubmed:pagination204-9lld:pubmed
pubmed-article:11357186pubmed:dateRevised2009-7-24lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:meshHeadingpubmed-meshheading:11357186...lld:pubmed
pubmed-article:11357186pubmed:year2001lld:pubmed
pubmed-article:11357186pubmed:articleTitleIschaemic preconditioning in the rat brain: a longitudinal magnetic resonance imaging (MRI) study.lld:pubmed
pubmed-article:11357186pubmed:affiliationSafety Assessment, GlaxoSmithKline, The Frythe, Welwyn, Herts AL6 9AR, UK.lld:pubmed
pubmed-article:11357186pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11357186pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11357186lld:pubmed